Full-Time

Supply Chain Manager

Posted on 5/8/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$107.3k - $137.9k/yr

+ Bonus + Stock-based long-term incentives

Mid, Senior

Remote in USA

Category
Supply Chain Management
Operations & Logistics
Required Skills
SAP Products
Requirements
  • Doctorate degree
  • Master’s degree and 2 years of SAP or IS system experience
  • Bachelor’s degree and 4 years of SAP or IS system experience
  • Associate’s degree and 8 years of SAP or IS system experience
  • High school diploma / GED and 10 years of SAP or IS system experience
Responsibilities
  • Support training of the clinical OTC process at Amgen to DSC and cross functional staff.
  • Document all clinical customizations in tracker in support of S4 HANA readiness.
  • Manage end-to-end process flow archive and ongoing workshops.
  • Manage audit readiness playbooks.
  • Support case justification for clinical enhancements.
  • Interpret customer’s needs to identify potential opportunities for improvements. Generate Business Requirements (BRD) documents to initiate enhancements per the intake process.
  • Act as change owner to support continuous improvement initiatives
  • Support and/or lead enhancements. Develop project achievements, adhere to timelines, utilize project management tools such as Smartsheet, communicate issues, ensure issue resolution, and ensure change management for business end users.
  • Act as primary tester for system enhancements and upgrades, which includes script authoring/approval, data preparation, test execution, defect resolution test approval.
  • Monitor iDoc failures and determine root cause of issues. Work with business and/or IS team to implement corrective actions.
  • Troubleshoot technical incidents with end users applying both internal resources and outside organizations such as External Trial Operations (ETO).
  • Partner with IS to assist with the resolution of technical incidents utilizing the Integrated Service Management (ISM) application. Point of contact for application issues, incidents, and troubleshooting. Manage timely closure of incidents.
Desired Qualifications
  • Experience with SAP Order to Cash functionality
  • Experience with SAP Plan to Stock functionality
  • Experience with SAP Staging Tables
  • Experience with Clinical Investigational Product
  • Experience with SAP Security
  • Experience with Electronic Trial Operator systems and interfaces
  • Experience with Logistics Service provider systems and interfaces
  • Experience with data acquisition tools, such as Spotfire
  • Experience with IS management tools, such as ServiceNow
  • Experience with computerized system validation testing
  • Experience with Project Management
  • Experience with Quality systems and processes such as Change Control and Deviations

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.

INACTIVE